Division of Hematology/Oncology


faculty photo

Jakub Svoboda, MD

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Data Safety and Monitoring Committee , Abramson Cancer Center
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
2 West Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-614-1846
Fax: 215-615-5888
B.A. (Biology)
Mercyhurst College (Erie, PA), 1994.
M.D. (Medicine)
Yale University School of Medicine, 2000.
Post-Graduate Training
Intern in Medicine, University of Pennsylvania, 2000-2001.
Resident in Medicine, University of Pennsylvania, 2001-2003.
Fellow in Hematology-Oncology, University of Pennsylvania, 2003-2006.
American Board of Internal Medicine, 2003.
American Board of Internal Medicine (Medical Oncology), 2006.
American Board of Internal Medicine (Hematology), 2007.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Chong Elise A, Ahmadi Tahamtan, Aqui Nicole, Svoboda Jakub, Nasta Sunita D, Mato Anthony R, Walsh Kristy M, Schuster Stephen J: Combination of lenalidomide and rituximab overcomes rituximab-resistance in patients with indolent B-cell and mantle cell lymphomas. Clinical cancer research : an official journal of the American Association for Cancer Research Jan 2015.

Huntington Scott F, Nasta Sunita D, Schuster Stephen J, Doshi Jalpa A, Svoboda Jakub: Utility of interim and end-of-treatment FDG-PET/CT in frontline therapy of patients with diffuse large B-cell lymphoma. Leukemia & lymphoma Page: 1-19, Jan 2015.

Shah Nirav N, Harrison Neil, Stonecypher Mark, Frank Dale, Amorosa Valerianna, Svoboda Jakub: Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis. Clinical lymphoma, myeloma & leukemia 14(5): e157-60, Oct 2014.

Nagle Sarah J, Chong Elise A, Chekol Seble, Shah Nirav N, Nasta Sunita D, Glatstein Eli, Plastaras John P, Torigian Drew A, Schuster Stephen J, Svoboda Jakub: The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma. Cancer medicine 4(1): 7-15, Sep 2014.

Frosch Zachary, Luskin Marlise R, Landsburg Daniel J, Schuster Stephen J, Svoboda Jakub, Loren Alison W, Porter David L, Stadtmauer Edward A, Nasta Sunita D: R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma. Clinical lymphoma, myeloma & leukemia 15(2): 92-7, Aug 2014.

Landsburg Daniel J, Nasta Sunita D, Svoboda Jakub, Morrissette Jennifer J D, Schuster Stephen J: 'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients. British Journal of Haematology 166(3): 369-74, Apr 2014.

Ahmadi Tahamtan, Chong Elise A, Gordon Amanda, Aqui Nicole A, Nasta Sunita D, Svoboda Jakub, Mato Anthony R, Schuster Stephen J: Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas. Cancer 120(2): 222-8, Jan 2014.

Nagle, SJ, Woo, K, Schuster, SJ, Nasta, SD, Stadtmauer, E, Mick, R, Svoboda, J: Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era. American Journal of Hematology 88(10): 890-894, OCT 2013.

Patel, V, Buckstein, M, Perini, R, Hill-Kayser, C, Svoboda, J, Plastaras, JP: Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective. Leukemia and Lymphoma 54(10): 2168-2176, OCT 2013.

Ahmadi T, McQuade J, Porter D, Frey N, Loren A W, Goldstein S C, Svoboda J, Stadtmauer E, Schuster S J, Nasta S D: Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance. Bone Marrow Transplantation 47(8): 1082-6, Aug 2012.

back to top
Last updated: 02/04/2015
The Trustees of the University of Pennsylvania

Clinical Briefings Blog Spot

Penn MD Forum title with Penn Medicine Shield and Twitter